m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT00578
|
[1], [2], [3], [4] | |||
: modification sites
Indirect
Enhancement
m6A modification
pri-miR-143
pri-miR-143
METTL3
Methylation
: m6A sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Methyltransferase-like 3 (METTL3) | WRITER | |||
| m6A Target | pri-miR-143 | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | RNA modification (RNAMod) >> 5-methylcytidine (m5C) | ||||
| Epigenetic Regulator | RNA cytosine C(5)-methyltransferase NSUN2 (NSUN2) | WRITER | View Details | ||
| Regulated Target | H19 imprinted maternally expressed transcript (H19) | View Details | |||
| Crosstalk Relationship | m5C → m6A | Enhancement | |||
| Crosstalk Mechanism | RNA modification indirectly impacts m6A modification through downstream signaling pathways | ||||
| Crosstalk Summary | NSUN2 interacts with H19 imprinted maternally expressed transcript (H19), increasing its m5C level and promoting its physical interaction with pri-miR-143, which was regulated by METTL3-mediated m6A modification. | ||||
In-vitro Model |
Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 | |
| NCI-H1975 | Lung adenocarcinoma | Homo sapiens | CVCL_1511 | ||
| A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | ||
| AC16 [Human hybrid cardiomyocyte] | Normal | Homo sapiens | CVCL_4U18 | ||
References
: modification sites
: m6A sites